Technology & Tools for Life Science

Conferences & Courses
World Preclinical Congress World Preclinical Congress
June 10-12, 2015 | Boston, MA
The World Preclinical Congress (WPC; formerly the World Pharma Congress), now in its 14th year, is making a commitment to focus predominantly on preclinical research and highlight the challenges and opportunities in early drug discovery and development.

Translational Imaging in Cancer Drug Development Translational Imaging in Cancer Drug Development
June 10-11, 2015 | Boston, MA
Imaging in Preclinical and First in Human Clinical Studies in Oncology Conference Imaging remains an important tool in oncology drug discovery and development.

Mastering Medicinal Chemistry Mastering Medicinal Chemistry
June 10-11, 2015 | Boston, MA
Cambridge Healthtech Institute’s Twelfth Annual Mastering Medicinal Chemistry will showcase informative, high quality case studies and successful strategies to tackle the problems facing the medicinal chemistry landscape.




Life Science Media Library
Digital PCR Experiment Design and Primer DVD Digital PCR Experiment Design and Primer DVD
October 6, 2014 |
The course will provide a broad overview of microfluidics as an enabling technology for point-of-care diagnostics. The course is constructed to provide a comprehensive overview of the field, starting with an introduction to microfluidics and its principles. Different manufacturing options will be discussed. Emphasis is put on the complete development process for commercial microfluidics-enabled POC-products, covering aspects of development strategies, application cases, markets as well as aspects of commercialization. The course covers the existing product landscape as well as exemplary disease cases with examples from molecular and immunodiagnostics. The course is suitable for scientists, technicians, engineers but also business developers who would like to develop a deeper understanding of microfluidics as a key technology for the development of new product in the POC markets
qPCR in Molecular Diagnostics qPCR in Molecular Diagnostics
February 12, 2013 |
Quantitative real-time PCR is a valuable technology used for diagnostics of diseases such as cancer and infectious diseases, and for the detection of bacterial, fungal and viral pathogens. This course covers aspects of incorporating qPCR into standard molecular diagnosis including the challenges involved, an overview of the technology available, and next steps.
Integrating Human Factors Engineering (HFE) into Drug Delivery Integrating Human Factors Engineering (HFE) into Drug Delivery
January 22, 2013 |
In this DVD, we will provide a baseline understanding of the regulatory need, common practices and real world examples of integrating Human Factors Engineering into a drug development activity. Key topics to be addressed: Why you should care: Regulatory expectations for the application of HFE What to avoid: Right and wrong ways to apply HFE to your project Lessons from the field: Real world examples of HFE




Publications, Reports, & Whitepapers
Prenatal Diagnostics: Invasive testing, noninvasive testing, and rising maternal screening methods for preeclampsia and preterm labor
New to insight Pharma Reports is Prenatal Diagnostics: Invasive testing, noninvasive testing, and rising maternal screening methods for preeclampsia and preterm labor. This report discusses improvements in invasive procedures (karyotyping vs. cytogenetics), and the rise of noninvasive screening methods and their impact on prenatal healthcare.
Vaccines: The End of Illness
This report analyzes recent trends in medicinal chemistry and evaluates their significance for advancing R&D productivity. We consider technological modalities and market dynamics, with an emphasis on outsourcing and user views on the implications of current practices.
Ocular Disorders: Rising Therapeutics, Technologies, and Devices
New to Insight Pharma Reports is: Ocular Disorders: Rising Therapeutics, Technologies, and Devices. This report covers several companies and their approach to targeting ocular diseases including wet and dry age-related macular degeneration (AMD) while also providing alternative therapeutic options for various ocular complications.